Cite
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
MLA
Han S, et al. “Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion.” Journal of Hepatocellular Carcinoma, vol. ume 7, Dec. 2020, pp. 403–12. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f598251c42a14635a7d6cc6e3f44aea8&authtype=sso&custid=ns315887.
APA
Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, & Kim BK. (2020). Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion. Journal of Hepatocellular Carcinoma, ume 7, 403–412.
Chicago
Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, et al. 2020. “Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion.” Journal of Hepatocellular Carcinoma ume 7 (December): 403–12. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.f598251c42a14635a7d6cc6e3f44aea8&authtype=sso&custid=ns315887.